Lynx1 Capital Management LP - 10%+ Owner at TScan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
TCRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Lynx1 Capital Management LP - trading volume in the past year for TScan Therapeutics, Inc.

Holdings reported by Lynx1 Capital Management LP for TScan Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Pre-funded Warrant (right to buy) 5M $35.6M $7.13 Apr 19, 2024 Indirect Common Stock
Common stock, $0.0001 par value per share 5.23M $22.7M $4.34 Nov 15, 2024 Indirect

Transactions reported by Lynx1 Capital Management LP for TScan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.